Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
Conduit Pharmaceuticals Inc. (CDT) had Consolidated Net Income/Loss of $-2.41M for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-2.41M |
|
-- |
|
-- |
|
$3.51M |
|
$-3.51M |
|
$1.11M |
|
$-2.41M |
|
$-2.41M |
|
$-2.41M |
|
$-2.41M |
|
|
Consolidated Net Income/Loss |
$-2.41M |
$-2.41M |
|
$-3.51M |
|
$-1.91M |
|
0.87M |
|
0.87M |
|
$-1.53 |
|
$-1.53 |
|
| Balance Sheet Financials | |
$2.71M |
|
$0.04M |
|
$1.48M |
|
$4.19M |
|
$10.74M |
|
-- |
|
$0.24M |
|
$10.99M |
|
$-6.79M |
|
$-6.79M |
|
$-6.79M |
|
1.38M |
|
| Cash Flow Statement Financials | |
$-9.68M |
|
$-0.04M |
|
$6.07M |
|
$4.23M |
|
$0.55M |
|
$-3.67M |
|
$1.63M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.25 |
|
-- |
|
-- |
|
-- |
|
-1.06 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-9.73M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
35.42% |
|
35.42% |
|
-57.38% |
|
35.42% |
|
$-4.91 |
|
$-11.22 |
|
$-11.17 |
|